Toll Free: 1-888-928-9744

Global Cancer Vaccines Market Professional Survey Report 2016

Published: May 30, 2016 | Pages: 106 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report
Mainly covers the following product types
The segment applications including

Segment regions including (the separated region report can also be offered) USA China Europe South America Japan Africa
The players list (Partly, Players you are interested in can also be added) Dendreon GlaxoSmithKline Merck Sanofi Vaccinogen Vaxon Biotech Vical Aduro BioTech Advantagene Advaxis Agenus AlphaVax Altor BioScience Amgen Antigen Express Argos Therapeutics Biothera Bristol-Myers Squibb Celldex Therapeutics Cel-Sci CureVac Cytos Galena Biopharma Gradalis Heat Biologics Immatics Inovio Pharmaceuticals Isa Pharmaceuticals Juvaris Biotherapeutics MedImmune NewLink Genetics Northwest Biotherapeutics Oxford BioMedica Prima BioMed Provectus Biopharmaceuticals With no less than 15 top producers. Data including (both global and regions): Market Size (both volume - K MT and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/MT, Cost, Gross margin etc. More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
 Table of Contents
1 Industry Overview of Cancer Vaccines 1.1 Definition and Specifications of Cancer Vaccines 1.1.1 Definition of Cancer Vaccines 1.1.2 Specifications of Cancer Vaccines 1.2 Classification of Cancer Vaccines 1.3 Applications of Cancer Vaccines 1.4 Industry Chain Structure of Cancer Vaccines 1.5 Industry Overview and Major Regions Status of Cancer Vaccines 1.5.1 Industry Overview of Cancer Vaccines 1.5.2 Global Major Regions Status of Cancer Vaccines 1.6 Industry Policy Analysis of Cancer Vaccines 1.7 Industry News Analysis of Cancer Vaccines 2 Manufacturing Cost Structure Analysis of Cancer Vaccines 2.1 Raw Material Suppliers and Price Analysis of Cancer Vaccines 2.2 Equipment Suppliers and Price Analysis of Cancer Vaccines 2.3 Labor Cost Analysis of Cancer Vaccines 2.4 Other Costs Analysis of Cancer Vaccines 2.5 Manufacturing Cost Structure Analysis of Cancer Vaccines 2.6 Manufacturing Process Analysis of Cancer Vaccines 3 Technical Data and Manufacturing Plants Analysis of Cancer Vaccines 3.1 Capacity and Commercial Production Date of Global Cancer Vaccines Major Manufacturers in 2015 3.2 Manufacturing Plants Distribution of Global Cancer Vaccines Major Manufacturers in 2015 3.3 R&D Status and Technology Source of Global Cancer Vaccines Major Manufacturers in 2015 3.4 Raw Materials Sources Analysis of Global Cancer Vaccines Major Manufacturers in 2015 4 Global Cancer Vaccines Overall Market Overview 4.1 2011-2016E Overall Market Analysis 4.2.1 2011-2015 Global Cancer Vaccines Capacity and Growth Rate Analysis 4.2.2 2015 Cancer Vaccines Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2011-2015 Global Cancer Vaccines Sales and Growth Rate Analysis 4.3.2 2015 Cancer Vaccines Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2011-2015 Global Cancer Vaccines Sales Price 4.4.2 2015 Cancer Vaccines Sales Price Analysis (Company Segment) 4.5 Gross Margin Analysis 4.5.1 2011-2015 Global Cancer Vaccines Gross Margin 4.5.2 2015 Cancer Vaccines Gross Margin Analysis (Company Segment) 5 Cancer Vaccines Regional Market Analysis 5.1 USA Cancer Vaccines Market Analysis 5.1.1 USA Cancer Vaccines Market Overview 5.1.2 USA 2011-2016E Cancer Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.1.3 USA 2011-2016E Cancer Vaccines Sales Price Analysis 5.1.4 USA 2015 Cancer Vaccines Market Share Analysis 5.2 China Cancer Vaccines Market Analysis 5.2.1 China Cancer Vaccines Market Overview 5.2.2 China 2011-2016E Cancer Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.2.3 China 2011-2016E Cancer Vaccines Sales Price Analysis 5.2.4 China 2015 Cancer Vaccines Market Share Analysis 5.3 Europe Cancer Vaccines Market Analysis 5.3.1 Europe Cancer Vaccines Market Overview 5.3.2 Europe 2011-2016E Cancer Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.3.3 Europe 2011-2016E Cancer Vaccines Sales Price Analysis 5.3.4 Europe 2015 Cancer Vaccines Market Share Analysis 5.4 South America Cancer Vaccines Market Analysis 5.4.1 South America Cancer Vaccines Market Overview 5.4.2 South America 2011-2016E Cancer Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.4.3 South America 2011-2016E Cancer Vaccines Sales Price Analysis 5.4.4 South America 2015 Cancer Vaccines Market Share Analysis 5.5 Japan Cancer Vaccines Market Analysis 5.5.1 Japan Cancer Vaccines Market Overview 5.5.2 Japan 2011-2016E Cancer Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Japan 2011-2016E Cancer Vaccines Sales Price Analysis 5.5.4 Japan 2015 Cancer Vaccines Market Share Analysis 5.6 Africa Cancer Vaccines Market Analysis 5.6.1 Africa Cancer Vaccines Market Overview 5.6.2 Africa 2011-2016E Cancer Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.6.3 Africa 2011-2016E Cancer Vaccines Sales Price Analysis 5.6.4 Africa 2015 Cancer Vaccines Market Share Analysis 6 Global 2011-2016E Cancer Vaccines Segment Market Analysis (by Type) 6.1 Global 2011-2016E Cancer Vaccines Sales by Type 6.2 Different Types Cancer Vaccines Product Interview Price Analysis 6.3 Different Types Cancer Vaccines Product Driving Factors Analysis 7 Global 2011-2016E Cancer Vaccines Segment Market Analysis (by Application) 7.1 Global 2011-2016E Consumption by Application 7.2 Different Application Product Interview Price Analysis 7.3 Different Application Product Driving Factors Analysis 8 Major Manufacturers Analysis of Cancer Vaccines 8.1 Dendreon 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.3 Dendreon 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Dendreon 2015 Cancer Vaccines Business Region Distribution Analysis 8.2 GlaxoSmithKline 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.3 GlaxoSmithKline 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 GlaxoSmithKline 2015 Cancer Vaccines Business Region Distribution Analysis 8.3 Merck 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.3 Merck 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Merck 2015 Cancer Vaccines Business Region Distribution Analysis 8.4 Sanofi 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.3 Sanofi 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Sanofi 2015 Cancer Vaccines Business Region Distribution Analysis 8.5 Vaccinogen 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.3 Vaccinogen 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Vaccinogen 2015 Cancer Vaccines Business Region Distribution Analysis 8.6 Vaxon Biotech 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.3 Vaxon Biotech 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Vaxon Biotech 2015 Cancer Vaccines Business Region Distribution Analysis 8.7 Vical 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.3 Vical 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Vical 2015 Cancer Vaccines Business Region Distribution Analysis 8.8 Aduro BioTech 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.3 Aduro BioTech 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Aduro BioTech 2015 Cancer Vaccines Business Region Distribution Analysis 8.9 Advantagene 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.3 Advantagene 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Advantagene 2015 Cancer Vaccines Business Region Distribution Analysis 8.10 Advaxis 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.3 Advaxis 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Advaxis 2015 Cancer Vaccines Business Region Distribution Analysis 8.11 Agenus 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.3 Agenus 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 Agenus 2015 Cancer Vaccines Business Region Distribution Analysis 8.12 AlphaVax 8.12.1 Company Profile 8.12.2 Product Picture and Specifications 8.12.3 AlphaVax 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.12.4 AlphaVax 2015 Cancer Vaccines Business Region Distribution Analysis 8.13 Altor BioScience 8.13.1 Company Profile 8.13.2 Product Picture and Specifications 8.13.3 Altor BioScience 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.13.4 Altor BioScience 2015 Cancer Vaccines Business Region Distribution Analysis 8.14 Amgen 8.14.1 Company Profile 8.14.2 Product Picture and Specifications 8.14.3 Amgen 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.14.4 Amgen 2015 Cancer Vaccines Business Region Distribution Analysis 8.15 Antigen Express 8.15.1 Company Profile 8.15.2 Product Picture and Specifications 8.15.3 Antigen Express 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.15.4 Antigen Express 2015 Cancer Vaccines Business Region Distribution Analysis 8.16 Argos Therapeutics 8.16.1 Company Profile 8.16.2 Product Picture and Specifications 8.16.3 Argos Therapeutics 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.16.4 Argos Therapeutics 2015 Cancer Vaccines Business Region Distribution Analysis 8.17 Biothera 8.17.1 Company Profile 8.17.2 Product Picture and Specifications 8.17.3 Biothera 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.17.4 Biothera 2015 Cancer Vaccines Business Region Distribution Analysis 8.18 Bristol-Myers Squibb 8.18.1 Company Profile 8.18.2 Product Picture and Specifications 8.18.3 Bristol-Myers Squibb 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.18.4 Bristol-Myers Squibb 2015 Cancer Vaccines Business Region Distribution Analysis 8.19 Celldex Therapeutics 8.19.1 Company Profile 8.19.2 Product Picture and Specifications 8.19.3 Celldex Therapeutics 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.19.4 Celldex Therapeutics 2015 Cancer Vaccines Business Region Distribution Analysis 8.20 Cel-Sci 8.20.1 Company Profile 8.20.2 Product Picture and Specifications 8.20.3 Cel-Sci 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.20.4 Cel-Sci 2015 Cancer Vaccines Business Region Distribution Analysis 8.21 CureVac 8.21.1 Company Profile 8.21.2 Product Picture and Specifications 8.21.3 CureVac 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.21.4 CureVac 2015 Cancer Vaccines Business Region Distribution Analysis 8.22 Cytos 8.22.1 Company Profile 8.22.2 Product Picture and Specifications 8.22.3 Cytos 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.22.4 Cytos 2015 Cancer Vaccines Business Region Distribution Analysis 8.23 Galena Biopharma 8.23.1 Company Profile 8.23.2 Product Picture and Specifications 8.23.3 Galena Biopharma 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.23.4 Galena Biopharma 2015 Cancer Vaccines Business Region Distribution Analysis 8.24 Gradalis 8.24.1 Company Profile 8.24.2 Product Picture and Specifications 8.24.3 Gradalis 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.24.4 Gradalis 2015 Cancer Vaccines Business Region Distribution Analysis 8.25 Heat Biologics 8.25.1 Company Profile 8.25.2 Product Picture and Specifications 8.25.3 Heat Biologics 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.25.4 Heat Biologics 2015 Cancer Vaccines Business Region Distribution Analysis 8.26 Immatics 8.26.1 Company Profile 8.26.2 Product Picture and Specifications 8.26.3 Immatics 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.26.4 Immatics 2015 Cancer Vaccines Business Region Distribution Analysis 8.27 Inovio Pharmaceuticals 8.27.1 Company Profile 8.27.2 Product Picture and Specifications 8.27.3 Inovio Pharmaceuticals 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.27.4 Inovio Pharmaceuticals 2015 Cancer Vaccines Business Region Distribution Analysis 8.28 Isa Pharmaceuticals 8.28.1 Company Profile 8.28.2 Product Picture and Specifications 8.28.3 Isa Pharmaceuticals 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.28.4 Isa Pharmaceuticals 2015 Cancer Vaccines Business Region Distribution Analysis 8.29 Juvaris Biotherapeutics 8.29.1 Company Profile 8.29.2 Product Picture and Specifications 8.29.3 Juvaris Biotherapeutics 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.29.4 Juvaris Biotherapeutics 2015 Cancer Vaccines Business Region Distribution Analysis 8.30 MedImmune 8.30.1 Company Profile 8.30.2 Product Picture and Specifications 8.30.3 MedImmune 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.30.4 MedImmune 2015 Cancer Vaccines Business Region Distribution Analysis 8.31 NewLink Genetics 8.31.1 Company Profile 8.31.2 Product Picture and Specifications 8.31.3 NewLink Genetics 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.31.4 NewLink Genetics 2015 Cancer Vaccines Business Region Distribution Analysis 8.32 Northwest Biotherapeutics 8.32.1 Company Profile 8.32.2 Product Picture and Specifications 8.32.3 Northwest Biotherapeutics 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.32.4 Northwest Biotherapeutics 2015 Cancer Vaccines Business Region Distribution Analysis 8.33 Oxford BioMedica 8.33.1 Company Profile 8.33.2 Product Picture and Specifications 8.33.3 Oxford BioMedica 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.33.4 Oxford BioMedica 2015 Cancer Vaccines Business Region Distribution Analysis 8.34 Prima BioMed 8.34.1 Company Profile 8.34.2 Product Picture and Specifications 8.34.3 Prima BioMed 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.34.4 Prima BioMed 2015 Cancer Vaccines Business Region Distribution Analysis 8.35 Provectus Biopharmaceuticals 8.35.1 Company Profile 8.35.2 Product Picture and Specifications 8.35.3 Provectus Biopharmaceuticals 2015 Cancer Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.35.4 Provectus Biopharmaceuticals 2015 Cancer Vaccines Business Region Distribution Analysis 9 Development Trend of Analysis of Market 9.1 Global Market Trend Analysis 9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast 9.1.2 Global 2016-2021 Sales Price Forecast 9.1.3 Global 2016-2021 Gross Margin Forecast 9.2 Regional Market Trend 9.2.1 USA 2016-2021 Cancer Vaccines Consumption Forecast 9.2.2 China 2016-2021 Cancer Vaccines Consumption Forecast 9.2.3 Europe 2016-2021 Cancer Vaccines Consumption Forecast 9.2.4 South America 2016-2021 Cancer Vaccines Consumption Forecast 9.2.5 Japan 2016-2021 Cancer Vaccines Consumption Forecast 9.2.6 Africa 2016-2021 Cancer Vaccines Consumption Forecast 9.3 Market Trend (Product type) 9.4 Market Trend (Application) 10 Cancer Vaccines Marketing Model Analysis 10.1 Cancer Vaccines Regional Marketing Model Analysis 10.2 Cancer Vaccines International Trade Model Analysis 10.3 Traders or Distributors with Contact Information of Cancer Vaccines by Regions 10.4 Cancer Vaccines Supply Chain Analysis 11 Consumers Analysis of Cancer Vaccines 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis … 12 New Project Investment Feasibility Analysis of Cancer Vaccines 12.1 New Project SWOT Analysis of Cancer Vaccines 12.2 New Project Investment Feasibility Analysis of Cancer Vaccines 13 Conclusion of the Global Cancer Vaccines Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposable

Read More...

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...
Choose License Type
Single User - US $3500
Multi User - US $7000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify